Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection

doi:10.4251/wjgo.v12.i4.467

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6619)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

374

WORD

198

HTML

3316

Figures (1-5)

305

Tables (1-4)

256

Sum=4449

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

711

Download

1459

Sum=2170

Apr 15, 2020 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Apr 15, 2020; 12(4): 467-482
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.467

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curves for overall survival and recurrence-free survival stratified by systemic immune-inflammation index (A and D), neutrophil-to-lymphocyte ratio (B and E) and platelet-to-lymphocyte ratio (C and F) in the validation cohort. SII: Systemic immune-inflammation index; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio.

Citation: Li H, Wang JJ, Zhang M, Ren B, Li JX, Xu L, Wu H. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World J Gastrointest Oncol 2020; 12(4): 467-482
URL: https://www.wjgnet.com/1948-5204/full/v12/i4/467.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i4.467